These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7707492)

  • 41. Phenylbutazone kinetics and metabolite concentrations in the horse after five days of administration.
    Soma LR; Gallis DE; Davis WL; Cochran TA; Woodward CB
    Am J Vet Res; 1983 Nov; 44(11):2104-9. PubMed ID: 6650958
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PK-PD integration and PK-PD modelling of nonsteroidal anti-inflammatory drugs: principles and applications in veterinary pharmacology.
    Lees P; Giraudel J; Landoni MF; Toutain PL
    J Vet Pharmacol Ther; 2004 Dec; 27(6):491-502. PubMed ID: 15601443
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of body weight on the pharmacokinetics of flunixin meglumine in miniature horses and quarter horses.
    Lee CD; Maxwell LK
    J Vet Pharmacol Ther; 2014 Feb; 37(1):35-42. PubMed ID: 23659780
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of the acute-phase response on in vitro drug metabolism and plasma protein binding in the horse.
    Mills PC; Ng JC; Auer DE
    Vet Res Commun; 1997 Jul; 21(5):361-8. PubMed ID: 9232780
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacodynamic evaluation of the peripheral pain inhibition by carprofen and flunixin in the horse.
    Schatzmann U; Gugelmann M; Von Cranach J; Ludwig BM; Rehm WF
    Schweiz Arch Tierheilkd; 1990; 132(9):497-504. PubMed ID: 2267568
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics of phenylbutazone in neonatal foals.
    Wilcke JR; Crisman MV; Sams RA; Gerken DF
    Am J Vet Res; 1993 Dec; 54(12):2064-7. PubMed ID: 8116939
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics and effects on thromboxane B2 production following intravenous administration of flunixin meglumine to exercised thoroughbred horses.
    Knych HK; Arthur RM; McKemie DS; Chapman N
    J Vet Pharmacol Ther; 2015 Aug; 38(4):313-20. PubMed ID: 25582761
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics of phenylbutazone in mature Holstein bulls: steady-state kinetics after multiple oral dosing.
    Williams RJ; Boudinot FD; Smith JA; Knight AP
    Am J Vet Res; 1990 Mar; 51(3):371-5. PubMed ID: 2316912
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The disposition of suxibuzone in the horse.
    Delbeke FT; Vynckier L; Debackere M
    J Vet Pharmacol Ther; 1993 Sep; 16(3):283-90. PubMed ID: 8230399
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of adverse effects of phenylbutazone, flunixin meglumine, and ketoprofen in horses.
    MacAllister CG; Morgan SJ; Borne AT; Pollet RA
    J Am Vet Med Assoc; 1993 Jan; 202(1):71-7. PubMed ID: 8420909
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma concentrations of flunixin in the horse: its relationship to thromboxane B2 production.
    Soma LR; Uboh CE; Rudy J; Fegely J
    J Vet Pharmacol Ther; 1992 Sep; 15(3):292-300. PubMed ID: 1433493
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Flunixin in the cat: a pharmacodynamic, pharmacokinetic and toxicological study.
    Taylor PM; Winnard JG; Jefferies R; Lees P
    Br Vet J; 1994; 150(3):253-62. PubMed ID: 8044665
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Experimental uses of flunixin meglumine and phenylbutazone in food-producing animals.
    Kopcha M; Ahl AS
    J Am Vet Med Assoc; 1989 Jan; 194(1):45-9. PubMed ID: 2644181
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of single-dose intravenous phenylbutazone on experimentally induced, reversible lameness in the horse.
    Foreman JH; Barange A; Lawrence LM; Hungerford LL
    J Vet Pharmacol Ther; 2008 Feb; 31(1):39-44. PubMed ID: 18177317
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of Intravenous Flunixin Meglumine, Phenylbutazone, and Acupuncture on Ocular Pain Scores in the Horse: A Pilot Study.
    Makra Z; Csereklye N; Riera MM; McMullen RJ; Veres-Nyéki K
    J Equine Vet Sci; 2021 Mar; 98():103375. PubMed ID: 33663725
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics of flunixin meglumine in donkeys, mules, and horses.
    Coakley M; Peck KE; Taylor TS; Matthews NS; Mealey KL
    Am J Vet Res; 1999 Nov; 60(11):1441-4. PubMed ID: 10566824
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modulation of arachidonic acid metabolism in endotoxic horses: comparison of flunixin meglumine, phenylbutazone, and a selective thromboxane synthetase inhibitor.
    Moore JN; Hardee MM; Hardee GE
    Am J Vet Res; 1986 Jan; 47(1):110-3. PubMed ID: 3080926
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A pharmacokinetic/pharmacodynamic approach vs. a dose titration for the determination of a dosage regimen: the case of nimesulide, a Cox-2 selective nonsteroidal anti-inflammatory drug in the dog.
    Toutain PL; Cester CC; Haak T; Laroute V
    J Vet Pharmacol Ther; 2001 Feb; 24(1):43-55. PubMed ID: 11348486
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PHARMACOKINETICS OF A SINGLE ORAL DOSE OF FLUNIXIN MEGLUMINE IN THE WHITE RHINOCEROS (
    East B; Tell L; Citino SB; Fredholm DV; Gamble K; Fajt V
    J Zoo Wildl Med; 2019 Jun; 50(2):322-329. PubMed ID: 31260196
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in clinically normal horses and donkeys.
    Mealey KL; Matthews NS; Peck KE; Ray AC; Taylor TS
    Am J Vet Res; 1997 Jan; 58(1):53-5. PubMed ID: 8989496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.